|
Reliability
|
“… information is reliable when it is transmitted by an authoritative source …”
|
|
“… world-famous opinion leaders … big shots, who have great experience and have done pivotal studies … when they talk, we just listen …”
|
|
(in scientific research) “… the presence of authoritative and independent researchers is important …”
|
|
(in scientific journals) “…drugs can be evaluated by researchers outside the sponsor company …”
|
|
“… if the goal is improving patient care I trust it … I don’t if we talk about piddling …
|
|
Completeness
|
“… it’s necessary to look at everything … let’s not just look at positive data … every drug has weaknesses and knowing about them would bring added value to info …”
|
|
“ … comparative information to understand which drug is better for one patient and which for another one …”
|
|
“… if you don’t relate information to everyday practice, what is the use of it?…”
|
|
Usability
|
“… easily accessible, through the web … in Pubmed … possibly free of charge …”
|
|
“… not too detailed … or pompous … it should be strict to the point … providing hints that I can deepen on my own …”
|
|
“… when I ask for information, drug reps bring it to me the day after …”
|
|
“… I like information targeting specific needs … personalized …”
|
|
(guidelines refer to populations) “different from your own patients … in different countries they say different things … you cannot read them in one minute … they are huge …”
|
|
Exchange
|
“… I would like talking with colleagues … they may have more experience with specific types of patients … sometimes I don’t know how to manage them… I’d like getting help to choose the right drug for each patient …”
|
|
“… people with field experience … with knowledge that you can’t find anywhere …”
|
|
“… information-sharing is really enriching … it creates synergy … it is quick, maybe directly at bedside … it refers to real situations, unlike statistics in congresses …”
|
|
“… let’s talk about real cases … there is a wide array of patients … they are different from theory … we also cure immigrants …”
|
|
Transparency – conflicts of interest
|
(drug reps) “… you know which side they are on and they are honest in admitting that …”
|
|
(sponsored symposia) “… it is clear who is behind them … knowing it, we don’t have any problem …”
|
